- Acid-PEG9-NHS ester
-
-
2025-06-07
- CAS:1895916-27-4
- Min. Order: 500mg
- Purity: >98.00%
- Supply Ability: 500mg
|
| | Acid-PEG9-NHS ester Basic information |
| Product Name: | Acid-PEG9-NHS ester | | Synonyms: | Acid-PEG9-NHS ester;COOH-PEG9-NHS;COOH-PEG9-SPA;4,7,10,13,16,19,22,25,28-Nonaoxahentriacontanedioic acid, 1-(2,5-dioxo-1-pyrrolidinyl) ester | | CAS: | 1895916-27-4 | | MF: | C26H45NO15 | | MW: | 611.63 | | EINECS: | | | Product Categories: | peg | | Mol File: | 1895916-27-4.mol |  |
| | Acid-PEG9-NHS ester Chemical Properties |
| Boiling point | 685.1±65.0 °C(Predicted) | | density | 1.25±0.1 g/cm3(Predicted) | | pka | 4.28±0.10(Predicted) |
| | Acid-PEG9-NHS ester Usage And Synthesis |
| Description | Acid-PEG9-NHS ester is a PEG linker containing a carboxylic acid and an NHS ester. The hydrophilic PEG spacer increases solubility in aqueous media. The terminal carboxylic acid can react with primary amine groups in the presence of activators (e.g. EDC, or HATU) to form a stable amide bond. The NHS ester can be used to label the primary amines (-NH2) of proteins, amine-modified oligonucleotides, and other amine-containing molecules. | | Uses | Acid-PEG9-NHS ester is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. | | IC 50 | PEGs | | References | [1] An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562 DOI:10.1016/j.ebiom.2018.09.005 |
| | Acid-PEG9-NHS ester Preparation Products And Raw materials |
|